4D Lifetec Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $25.6M

  • Investors
  • 3

4D Lifetec General Information

Description

Developer of a liquid biopsy platform designed to revolutionize early cancer detection. The company's proprietary immuno-oncological biomarker deoxyribonucleic acid damage sensitivity detects cancer at its earliest stages and enhances immunological high-throughput blood assays offering peace of mind and proactive well-being protection, enabling healthcare professionals to timely intervene and start with treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Gewerbestrasse 8
  • 6330 Cham
  • Switzerland
+41 041
Primary Industry
Diagnostic Equipment
Corporate Office
  • Gewerbestrasse 8
  • 6330 Cham
  • Switzerland
+41 041

4D Lifetec Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

4D Lifetec Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 18-Oct-2023 $25.6M Completed Generating Revenue
10. Later Stage VC (Series B2) 31-Dec-2022 Completed Generating Revenue
9. Later Stage VC (Series B1) 23-May-2022 Completed Generating Revenue
8. Later Stage VC (Series B1) 01-Nov-2020 Completed Clinical Trials - General
7. Later Stage VC (Series A) 12-Sep-2019 Completed Pre-Clinical Trials
6. Accelerator/Incubator 27-May-2019 Completed Pre-Clinical Trials
5. Early Stage VC (Series A2) 01-May-2018 Completed Product In Beta Test
4. Early Stage VC (Series A1) 01-Jul-2016 Completed Product Development
3. Grant 01-Dec-2015 $637K $7.22M Completed Startup
2. Seed Round 01-May-2015 $2.19M $7.22M Completed Startup
To view 4D Lifetec’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

4D Lifetec Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a liquid biopsy platform designed to revolutionize early cancer detection. The company's proprietary immuno
Diagnostic Equipment
Cham, Switzerland
6 As of 2023

Boston, MA
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

4D Lifetec Competitors (5)

One of 4D Lifetec’s 5 competitors is Foundation Medicine, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Foundation Medicine Formerly VC-backed Boston, MA
Myriad Genetics Corporation Salt Lake City, UT
Exact Sciences Formerly VC-backed Madison, WI
GRAIL Formerly VC-backed Menlo Park, CA
Guardant Health Formerly VC-backed Palo Alto, CA
You’re viewing 5 of 5 competitors. Get the full list »

4D Lifetec Patents

4D Lifetec Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021363573-A1 Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility Pending 22-Oct-2020
AU-2021363573-A9 Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility Pending 22-Oct-2020
EP-4232821-A1 Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility Active 22-Oct-2020
EP-4232821-B1 Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility Active 22-Oct-2020
EP-4232821-C0 Dna damage sensitivity as a new biomarker for detection of cancer and cancer susceptibility Active 22-Oct-2020 G01N33/575
To view 4D Lifetec’s complete patent history, request access »

4D Lifetec Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

4D Lifetec Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xlife Sciences Venture Capital Minority
Venturelab Accelerator/Incubator Minority
Swiss Government Government
To view 4D Lifetec’s complete investors history, request access »

4D Lifetec FAQs

  • When was 4D Lifetec founded?

    4D Lifetec was founded in 2014.

  • Where is 4D Lifetec headquartered?

    4D Lifetec is headquartered in Cham, Switzerland.

  • What is the size of 4D Lifetec?

    4D Lifetec has 6 total employees.

  • What industry is 4D Lifetec in?

    4D Lifetec’s primary industry is Diagnostic Equipment.

  • Is 4D Lifetec a private or public company?

    4D Lifetec is a Private company.

  • What is 4D Lifetec’s current revenue?

    The current revenue for 4D Lifetec is .

  • How much funding has 4D Lifetec raised over time?

    4D Lifetec has raised $60.7M.

  • Who are 4D Lifetec’s investors?

    Xlife Sciences, Venturelab, and Swiss Government have invested in 4D Lifetec.

  • Who are 4D Lifetec’s competitors?

    Foundation Medicine, Myriad Genetics, Exact Sciences, GRAIL, and Guardant Health are competitors of 4D Lifetec.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process